Gene · 9780
Papers3,250
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
381 to 400 of 3,250
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Piezo1 Regulates ZnT1-Mediated Zinc Homeostasis in Ulcerative Colitis. | Inflammation | 2026 | 41586934 | PubTator, text mining | PubMed |
| Stiff matrix promotes lung cancer cell migration through down-regulating the Piezo1 channel expression to facilitate Ca2+-dependent filopodia formation. | Mater Today Bio | 2026 | 41585435 | PubTator, text mining | PubMed |
| Spatiotemporal Regulation of Ligand Trafficking and TLR9 Activation by PIEZO1 in Human Plasmacytoid Dendritic Cells. | Research (Wash D C) | 2026 | 41583391 | PubTator, text mining | PubMed |
| Does adding physical activity improve spinal bone mineral density in postmenopausal women?: A cross-sectional analysis of NHANES 2011 to 2018. | Medicine (Baltimore) | 2026 | 41578603 | PubTator, text mining | PubMed |
| A functional and robust cellular model for high-throughput screening of piezo1 modulators. | Sci Rep | 2026 | 41577940 | PubTator, text mining | PubMed |
| Stress vesicles link epidermal mechanotransduction to stem cell differentiation. | Nat Commun | 2026 | 41571638 | PubTator, text mining | PubMed |
| A Self-Reinforcing Pathway Linking PIEZO1 and 3-Carboxy-4-Methyl-5-Propyl-2-Furanpropionate, a Renal Retention Solute, with CKD Progression. | J Am Soc Nephrol | 2026 | 41563828 | PubTator, text mining | PubMed |
| Authors' Reply: A Self-Reinforcing Pathway Linking PIEZO1 and 3-Carboxy-4-Methyl-5-Propyl-2-Furanpropionate, a Renal Retention Solute, with CKD Progression. | J Am Soc Nephrol | 2026 | 41563824 | PubTator, text mining | PubMed |
| Osteoimmunology uncovered: How macrophages and biomaterials revolutionize bone healing. | Mater Today Bio | 2026 | 41560822 | PubTator, text mining | PubMed |
| Biomaterial-assisted neuralization strategies for tissue engineering applications. | Mater Today Bio | 2026 | 41560813 | PubTator, text mining | PubMed |
| Hydrogels Targeting Mechanical-biological signaling transitions of interleukin-33 alleviates intervertebral-disc degeneration. | Mater Today Bio | 2026 | 41560790 | PubTator, text mining | PubMed |
| Urothelial Piezo1 channel contributes to BOO-induced inflammation, EMT, and bladder fibrosis via activation of NLRP3 inflammasome. | J Transl Med | 2026 | 41559677 | PubTator, text mining | PubMed |
| Piezo1-A Key Pathogenic Factor in Breast Implant-Associated Capsular Contracture. | Aesthetic Plast Surg | 2026 | 41559393 | PubTator, text mining | PubMed |
| Exploring the Therapeutic Potential of Piezo1 in Ageing-Related Neurodegenerative Diseases. | J Mol Neurosci | 2026 | 41557125 | PubTator, text mining | PubMed |
| Supramolecular helicity dependent osteogenesis and angiogenesis crosstalk of periodontal ligament stem cell. | Bioact Mater | 2026 | 41551758 | PubTator, text mining | PubMed |
| Genetic differences in familial adenomatous polyposis syndrome in a Hungarian population: A prospective single center study. | World J Gastroenterol | 2026 | 41551532 | PubTator, text mining | PubMed |
| Oxidative stress-driven transcriptomic remodeling in human astrocytes reveals network signatures associated with neurodegenerative and cardiovascular processes. | Comput Struct Biotechnol J | 2026 | 41550140 | PubTator, text mining | PubMed |
| Insect salivary effectors disrupt PIEZO1-centric mechanoimmunity against piercing-sucking vectors. | Cell Rep | 2026 | 41548217 | PubTator, text mining | PubMed |
| Organoids for disease modeling and treatment: state-of-the-art. | Exp Hematol Oncol | 2026 | 41545895 | PubTator, text mining | PubMed |
| Insights into the role of the mechanosensitive Piezo1 channel and signaling mechanisms in CNS functions and diseases. | Neurosci Biobehav Rev | 2026 | 41544798 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/9780/papers?page=20